HCA Healthcare, Inc. (NYSE: HCA) announces the following Webcast:
What: HCA Healthcare, Inc. 4Q Earnings Release Call
When: Friday, January 27, 2023 at 9:00 am central (10:00 am eastern)
How: Live Audio over the Internet:
https://investor.hcahealthcare.com/events-and-presentations/default.aspx
If you are unable to listen during the live webcast, the call will be archived on the web site https://investor.hcahealthcare.com/events-and-presentations/default.aspx.
| Last Trade: | US$335.55 |
| Daily Change: | -5.07 -1.49 |
| Daily Volume: | 974,226 |
| Market Cap: | US$84.990B |
February 20, 2025 February 18, 2025 October 25, 2024 | |
Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MORE
Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MORE
